Clinical Trials on 冠状动脉疾病伴心肌梗死 in United States
总计2454个结果
-
Scripps HealthNational Center for Research Resources (NCRR)完全的
-
Inova Health Care ServicesCorMatrix Cardiovascular, Inc.终止
-
Medical University of South CarolinaAstellas Pharma US, Inc.完全的
-
First Affiliated Hospital of Harbin Medical University未知
-
Cardiopulmonary Research Science and Technology...Maquet Cardiovascular完全的
-
Cardiovascular Imaging Technologies完全的
-
Abbott Medical Devices完全的
-
Cardiovascular Imaging TechnologiesAstellas Pharma US, Inc.未知
-
Gilead SciencesAstellas Pharma US, Inc.完全的
-
VA Office of Research and DevelopmentParke-Davis; Fournier Labs完全的
-
LifeBridge HealthUniversity of Maryland招聘中
-
InfraredxBright Research Partners完全的
-
Spirocor终止Severe Coronary Artery Disease (S-CAD)美国
-
Astellas Pharma Global Development, Inc.完全的使用单光子发射计算机断层扫描 (SPECT) 进行心肌灌注成像 (MPI) 与单独使用 Regadenoson 相比,在不充分的运动压力测试后评估 Regadenoson 给药的研究 (EXERRT)冠状动脉疾病 (CAD)美国, 秘鲁, 阿根廷, 波多黎各
-
Abbott Medical Devices完全的
-
Abbott Medical DevicesBristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Baim Institute for Clinical Research完全的心肌缺血 | 冠状动脉疾病 | 冠心病 | 冠状动脉慢性完全闭塞 | 冠状动脉再狭窄 | 血管疾病 | 冠状动脉狭窄美国
-
General University Hospital, PragueUniversity of Iowa; Loyola University Chicago; Ministry of Health, Czech Republic; Czech Ministry...未知
-
Rigshospitalet, DenmarkNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Medstar Health Research Institute撤销
-
Rebecca Torguson完全的
-
National Heart, Lung, and Blood Institute (NHLBI)完全的
-
University National Heart Hospital未知
-
Volcano Corporation完全的
-
Eli Lilly and CompanyDaiichi Sankyo, Inc.完全的
-
SonoMedica, Inc.Medstar Health Research Institute终止
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)招聘中